Abstract:Aims/hypothesis: MicroRNAs are being sought as biomarkers for the early identification of type 2 diabetes. This study aimed to synthesise the evidence from microRNA-type 2 diabetes association studies and microRNA-regulated type 2 diabetes pathway delineation studies that met stringent quality criteria to identify and validate microRNAs of both statistical and biological significance as type 2 diabetes biomarkers. Methods: Eligible controlled studies on microRNA expression profiling of type 2 diabetes were retrieved from PubMed, ScienceDirect and Web of Science. MicroRNA-regulated type 2 diabetes pathway delineation studies were conducted by integrating and cross-verifying the data from miRTarBase, TransmiR, miRecords, TargetScanHuman, the Kyoto Encyclopedia of Genes and Genomes (KEGG) and the Retraction Watch database. Before meta-analysis, quality assessment was performed according to the corresponding reporting guidelines for evidence-based medicine. To select the most statistically significant microRNAs, we conducted extensive meta-analyses according to the latest methodology. Subgroup and sensitivity analyses were carried out to further examine the microRNA candidates for their tissue specificity and blood fraction specificity and the robustness of the evidence. Signalling pathway impact analysis of dysregulated microRNAs identified from meta-analyses was performed to select biologically significant microRNAs that were enriched in our newly built microRNA-regulated pathways. Results: Of the 404 differentially expressed microRNAs identified in the 156 controlled profiling studies with a combined sample size of >15,000, only 60 were both consistently and significantly dysregulated in human type 2 diabetes. No microRNAs were both consistently and significantly dysregulated in multiple tissues according to subgroup analyses. In total, 58 microRNAs were found to be robust in sensitivity analyses. A total of 1966 pathway delineation studies were identified, including 3290 microRNA-target interactions, which were further combined with KEGG pathways, producing 225 microRNA-regulated pathways. Impact analysis found that 16 dysregulated microRNAs identified from extensive meta-analyses were statistically significantly enriched in the augmented KEGG type 2 diabetes pathway. Conclusions/interpretation: Sixteen microRNAs met the criteria for biomarker selection. In terms of both significance and relevance, the order of priority for verification of these microRNAs is as follows: miR-29a-3p, miR-221-3p, miR-126-3p, miR-26a-5p, miR-503-5p, miR-100-5p, miR-101-3p, mIR-103a-3p, miR-122-5p, miR-199a-3p, miR-30b-5p, miR-130a-3p, miR-143-3p, miR-145-5p, miR-19a-3p and miR-311-3p. Registration: PROSPERO registration number CRD42017081659.

Circulating microRNA profiling identifies microRNAs linked to prediabetes associated with alcohol dependence syndrome

Circulating MicroRNAs As Potential Biomarkers for Alcoholic Steatohepatitis.

Analysis of Differentially Expressed Genes and Micrornas in Alcoholic Liver Disease

Pattern of Microrna Expression Associated with Different Stages of Alcoholic Liver Disease in Rat Models

Circulating miRNAs as Novel Diagnostic Biomarkers in Nonalcoholic Fatty Liver Disease: A Systematic Review and Meta-Analysis.

Differential Expression of Micrornas in Plasma of Patients with Prediabetes and Newly Diagnosed Type 2 Diabetes

miRNAs in patients with alcoholic liver disease: a systematic review and meta-analysis

Significance of serum microRNAs in pre-diabetes and newly diagnosed type 2 diabetes: a clinical study

Abstract P124: Human Small Artery MicroRNA Expression Profiles: Changes in Type 2 Diabetes and Associations with Endothelial Function

MicroRNA biomarkers of type 2 diabetes: evidence synthesis from meta-analyses and pathway modelling

Serum microRNA expression profiles and bioinformatics analysis in type 2 diabetes mellitus patients with Pi-deficiency syndrome

Salivary microRNAs identified by small RNA sequencing and machine learning as potential biomarkers of alcohol dependence.

Identification of MicroRNAs Associated with Prediabetic Status in Obese Women

Serum Mir-23A, a Potential Biomarker for Diagnosis of Pre-Diabetes and Type 2 Diabetes

Circulating miRNA Profiles Associated With Hyperglycemia in Patients With Type 1 Diabetes

RNA sequencing identified specific circulating miRNA biomarkers for early detection of diabetes retinopathy.

Investigating the altered expression of miR-486-5p and miR-novel-chr1_40444 in dysglycemia in a South African population

Altered Serum Microrna Expression Profile in Subjects with Heroin and Methamphetamine Use Disorder.

Association Between Diagnostic Micrornas of Non-Alcoholic Fatty Liver Disease and Type 2 Diabetes: A Meta-Analysis

Circulating microRNAs and diabetes mellitus: a novel tool for disease prediction, diagnosis, and staging?

Increased serum microRNAs are closely associated with the presence of microvascular complications in type 2 diabetes mellitus